Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q2 EPS of ($0.57), $0.02 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.